More articles from Selected Abstracts-HMORN 2013: HMORN Administrative and Technical

• B1-1: Get to Know the HMORN and Its Key Tools and Processes

  Ella Thompson, Jeffrey Braff, Jenilee Christy, Tyler Ross and Daniel Ng

  • Clinical Medicine & Research September 2013, 11 (3) 163.2;
  • DOI: https://doi.org/10.3121/cmr.2013.1176.b1-1
• B1-2: The New Federal Conflict of Interest (COI) Regulations - One Step Forward?

  Jeffrey Braff

  • Clinical Medicine & Research September 2013, 11 (3) 163.3;
  • DOI: https://doi.org/10.3121/cmr.2013.1176.b1-2
• B1-3: Member Engagement in Patient-Centered Research

  Sarah Madrid, Borsika Rabin, Jo Ann Shoup and Elizabeth Bayliss

  • Clinical Medicine & Research September 2013, 11 (3) 163.4;
  • DOI: https://doi.org/10.3121/cmr.2013.1176.b1-3
• C1-1: Portfolio Management: Using Lean Tools to Support Project Teams with Grant Management

  Stephen Reinig

  • Clinical Medicine & Research September 2013, 11 (3) 164.1;
  • DOI: https://doi.org/10.3121/cmr.2013.1176.c1-1
• C1-2: The Division of Research Comprehensive Clinical Research Unit Pre-Award Process and Budgeting for Clinical Trials

  Nanette Hock

  • Clinical Medicine & Research September 2013, 11 (3) 164.2;
  • DOI: https://doi.org/10.3121/cmr.2013.1176.c1-2
• C1-4: Preparing for FDA Bioresearch Monitoring (BIMO) and Good Clinical Research Practice (GCP) Inspections: Fundamentals for KP Clinical Trial Sites

  Nanette Hock

  • Clinical Medicine & Research September 2013, 11 (3) 164.3;
  • DOI: https://doi.org/10.3121/cmr.2013.1176.c1-4
• PS3-5: Extending HMORN Partnerships: The New Midwest Research Network

  Jane Duncan, Andrew Nelson and Thomas Elliott

  • Clinical Medicine & Research September 2013, 11 (3) 165.1;
  • DOI: https://doi.org/10.3121/cmr.2013.1176.ps3-5